In the present study, we have demonstrated the synergistic enhancement of cytotoxic effects of the PI3K/Akt pathway inhibitors on AML cells with FLT3-ITD by selective inhibition of STAT5 by pimozide, which is widely used for treatment of neuropsychiatric disorders. This evidence concerns the gene AKT1 and acute myeloid leukemia.